Jackson Egen
3Patents
1h-index
29Co-inventors
40Inventor score
Filing activity: May 29, 2015 → Dec 18, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9763922B2 | Therapeutic compounds and uses thereof | Chemistry; Metallurgy | 8 | Active |
| US10005848B2 | Method of reducing blood glucose by administering RON agonists | Physics | 0 | Active |
| US11926672B2 | Mesothelin-targeted CD40 agonistic multispecific antibody constructs for the treatment of solid tumors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.